Gabriel Hortobagyi joins Galena SAB
This article was originally published in Scrip
Executive Summary
Oncology-focused Galena Biopharma has elected industry veteran Dr Gabriel Hortobagyi to its scientific advisory board. Dr Hortobagyi is a professor of medicine and chair of the department of breast medical oncology at the University of Texas MD Anderson Cancer Center, where he also holds the Nellie B. Connallly chair in breast cancer research. In addition, he is senior editor for The Oncologist, associate editor for several other oncology publications and a board member of the American Society of Clinical Oncology.